Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: A randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols

British Journal of Nutrition

Volumn 94, Issue 2, 2005, Pages 221-230

  Garcia de Lorenzo A ^a   Denia, R ^a   Atlan, P ^b   Martinez Ratero, S ^a   Le Brun, A ^b   Evard, D ^b   Bereziat, G ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Baxter SAS   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Burns; Lipid emulsion; Liver function tests; Olive oil; Parenteral nutrition

Indexed keywords

ADDAMEL; CERNEVIT; CLINOLEIC; CYTOKINE; DIHOMO GAMMA LINOLENIC ACID; GLUCOSE; GLYCEROL; INTERLEUKIN 6; LINOLEIC ACID; LIPID EMULSION; LIPOFUNDIN; LIPOFUNDINA; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MONOUNSATURATED FATTY ACID; NITROGEN; OLIVE OIL; PHOSPHOLIPID DERIVATIVE; PLASMA PROTEIN; PLASMA SUBSTITUTE; POLYUNSATURATED FATTY ACID; POTASSIUM; SATURATED FATTY ACID; SODIUM; SOYBEAN OIL; TRACE ELEMENT; VITAMIN;

ADULT; ARTICLE; BURN; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LUNG INFECTION; MALE; MEDICAL RECORD; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPSIS; SEPTICEMIA; STATISTICAL ANALYSIS; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BURNS; CHOLESTEROL; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; FEMALE; HUMANS; LINOLEIC ACID; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; PHOSPHOLIPIDS; PLANT OILS; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 25444453212     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20051467     Document Type: Article

References (76)

1. Alexander JW (1990) Mechanism of immunologic suppression in burn injury. J Trauma 30, 70S-75S.
2. Alpers DH (2001) Liver complications and failure in patients on home parenteral nutrition. Curr Opin Gastroenterol 17, 147-149.
3. Barlow Y (1994) T lymphocytes and immunosuppression in the burned patient: a review. Burns 20, 487-490.
4. Battistella FD, Widergren JT, Anderson JT, Siepler JK, Weber JC & MacColl K (1997) A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 43, 52-60.
5. Beau P, Barrioz T & Ingrand P (1994) Is parenteral nutrition-related cholestatic liver disease an infectious disease? Gastroenterol Clin Biol 18, 63-67.
6. Beau P, de Lédinghen V & Ingrand P (1995) Total parenteral nutrition-related liver disease and medium chain triglycerides lipid emulsions. Nutr Clin Metabol 9, 117-122.
7. Bellinati-Pires R, Waitzberg DL, Salgado MM & Carneiro-Sampaio MM (1993) Functional alterations of human neutrophils by medium-chain triglyceride emulsion: evaluation of phagocytosis, bacterial killing, and oxidative activity. J Leukoc Biol 53, 404-410.
8. Bone RC (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655.
9. Bouletreau P, Berrada K & Chambrier C (1996) Tolérance hépatique de l'émulsion lipidique ClinOleic®. Nutr Clin Métabol 10, 335-365.
10. Calder PC & Newsholme EA (1992) PUFAs suppress human peripheral blood lymphocytes proliferation and interleukin-2 production. Clin Sci 75, 695-700.
11. Capron JP, Gineston JL, Hervé MA & Braillon A (1983) Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet 1, 446-447.
12. Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, Ainaud P & Bohuon C (1997) Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns 23, 218-224.
13. Cavicchi M, Bean P, Crenn P, Degott C & Messing B (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132, 525-532.
14. Cetinkale O & Yazici Z (1997) Early postburn fatty acid profile in burn patients. Burns 23, 392-399.
15. Chambrier C, Guiraud M, Gibault JP, Labrosse H & Bouletreau P (1999) Medium- and long-chain triacylglycerols in postoperative patients: structured lipids versus a physical mixture. Nutrition 15, 274-277.
16. Charcon Castro MP, Jimenez Sesé B, Salvado Salvat J, Sabin Urquia P, Pascual Mostaza C & Planas Vila M (2000) Influence of two fatty emulsions with a different triglyceride composition on the lipid metabolism of the septicemic patient. Nutr Hosp 15, 13-17.
17. De Francesco A, Balzola FA, Come A, Le Brun A, Evard D, Atlan P, Dutot G & Balzola F (1999) Long-term safety of home parenteral nutrition (HPN) with a new olive oil-based lipid emulsion (LE): a randomised, double-blind, comparative trial. Clinical Nutrition 18, Suppl. 1, 46.
18. Deitch EA (1995) Nutrition support of the burn patient. In Nutrition in the Critically Ill Patient, pp. 735-750 [CH Lang, editor]. Philadelphia: WB Saunders.
19. Driss F, Darcet P, Delhaye N & Mendy F (1988) Effect of eicosapentanoic acid on RBC filterability and fatty acid composition. Clin Hemorrheol 8, 679-685.
20. Drost AC, Burleson DG, Cioffi WG Jr, Jordan BS, Mason AD Jr & Pruitt BA Jr (1993) Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 35, 335-339.
21. Endo S, Inada K, Yamada Y, et al. (1996) Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. J Med 27, 57-71.
22. Eritsland J (2000) Safety considerations of polyunsaturated fatty acids. Am J Clin Nutr 71, 197S-201S.
23. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein ME & Platt R (1990) Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 323, 301-308.
24. Friedman B & Deppe SA (2002) Nutritional considerations in the severely burned patient. In Nutritional Considerations in the Intensive Care Unit, pp. 245-258 [SA Shirota, RG Martindale and SD Scwaitzberg, editors]. Silver Spring, CO: Kendall/Hunt Publishing Company & ASPEN.
25. García-de-Lorenzo A (1983) Metronidazole, cholestasis and total parenteral nutrition. Lancet 21, 1161.
26. Garcia-de-Lorenzo A & Culebras JM (1992) Linoleic acid and the immune system. Controversies about lipid emulsions. Nutr Hosp 7, 377-387.
27. Garnacho-Montero J, Ortiz-Leyba C, Gamacho-Montero MC, Garcia-Garmendia JL, Perez-Paredes C, Moyano-Del Estad MR, Barrero-Almodovar A & Jimenez-Jimenez FJ (2002) Effects of three intravenous lipid emulsions on the survival and mononuclear phagocyte function of septic rats. Nutrition 18, 751-754.
28. Garrel DR, Razi M, Lariviere F, Jobin N, Naman N, Emptoz-Bonneton A & Pugeat MM (1995) Improved clinical status and length of care with low-fat nutrition support in burn patients. J Parenter Enter Nutr 19, 482-491.
29. German G, Barthold U, Lefering R, Raff T & Hartmann B (1997) The impact of risk factors and pre-existing conditions on the mortality of burn patients and the precision of predictive admission-scoring systems. Burns 23, 195-203.
30. Gobel Y, Koletzko B, Bohles HJ, Engelsberger I, Forget D, Le Brun A, Peters J & Zimmermann A (2003) Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 37, 161-167.
31. Goulet O, De Potter S, Antebi H, et al. (1999) Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in paediatric patients: a double blind randomized study. Am J Clin Nutr 70, 338-345.
32. Granato D, Blum S, Rössle C, Le Boucher J, Malnoe A & Dutot G (2000) Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enter Nutr 24, 113-118.
33. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM & Winchurch RA (1990) Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 54, 361-371.
34. Hageman JR, McCulloch K, Gora P, Olsen EK, Pachman L & Hunt CE (1983) Intralipid alterations in pulmonary prostaglandin metabolism and gas exchange. Crit Care Med 11, 794-798.
35. Herndon DN, Stein MD, Rutan TC, Abston S & Linares H (1987) Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 27, 195-204.
36. Herruzo-Cabrera R, Fernandez-Arjona M, Garcia-Torres V, Martinez-Ratero S, Lenguas-Portero F & Rey-Calero J (1995) Mortality evolution study of burn patients in a critical care burn unit between 1971 and 1991. Burns 21, 106-109.
37. Holman RT (1960) The ratio of trienoic:tetraenoic acids in the tissue lipids as a measure of essential fatty acid requirement. J Nutr 70, 405-410.
38. Karlstad MD, DeMichele SJ, Leathem WD & Peterson MB (1993) Effect of intravenous lipid emulsions enriched with gamma-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats. Crit Care Med 21, 1740-1749.
39. Kinsella JE, Lokesh B, Broughton S & Whelan J (1990) Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6, 24-44.
40. Kono H, Fujii H, Asakawa M, Matsuda M, Maki A & Matsumoto Y (2003) Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg 237, 246-255.
41. Kowal-Vern A, Walenga JM, Hoppensteadt D, Sharp-Pucci M & Gamelli RL (1994) Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 178, 357-362.
42. McManus AT, Mason AD Jr, McManus WF & Pruitt BA Jr (1985) Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur J Clin Microbiol 4, 219-223.
43. Masini JP, Fichelle A, Pescio M, Béréziat G, Desmonts JM & Lienhart A (1996) Tolérance clinique et biologique et effets sur les paramétres lipidiques de ClinOleic® comparé à l'Intralipide® chez des patients de réanimation chirurgicale. Nutr Clin Métabol 10, 21S-24S.
44. Montegut WJ & Lowry SF (1993) Nutrition in burn patients. Semin Nephrol 13, 400-408.
45. Morlion BJ, Torwesten E, Lessire H, Sturm G, Peskar BM, Furst P & Puchstein C (1996) The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. Metabolism 45, 1208-1213.
46. Moussa M, Le Boucher J, Garcia J, Tkaczuk J, Ragab J, Dutot G, Ohayon E, Ghisolfi J & Thouvenot JP (2000) In vivo effects of olive oil-based lipid emulsion on lymphocyte activation in rats. Clin Nutr 19, 49-54.
47. Nordenstrom J, Jarstrand C & Wirniek A (1979) Decreased chemotactic and random migration of leukocytes during intralipid infusion. Am J Clin Nutr 32, 2416-2420.
48. Pakula R, Konikoff FM, Moser AM, Greif F, Tietz A, Gilat T & Rubin M (1999) The short term lipid infusion on plasma and hepatic bile lipids in humans. Gut 45, 453-458.
49. Papini RP, Wilson AP, Steer JA, Hill G, McGrouther DA & Parkhouse N (1997) Plasma concentrations of tumour necrosis factor-alpha and interleukin-6 during burn wound surgery or dressing. Br J Plast Surg 50, 354-361.
50. Peck MD (1994) Interaction of lipids with immune function. I. Biochemical effects of dietary lipids on plasma membranes. J Nutr Biochem 5, 466-478.
51. Pelaez J, Garcia-de-Lorenzo A, Denia R, Martinez-Ratero S, Lopez J & Caparros T (1997) Nutritional support for the large burn patient. Nutr Hosp 12, 121-133.
52. Pratt VC, Tredget HE, Clandinin MT & Field CJ (2001) Fatty acid content of plasma lipids and erythrocyte phospholipids are altered following burn injury. Lipids 36, 675-682.
53. Pratt VC, Tredget HE, Clandinin MT & Field CJ (2002) Alterations in lymphocyte function and relation to phospholipid composition after burn injury in humans. Crit Care Med 30, 1753-1761.
54. Reimer T, Morlion B, Fürst P, Le Brun A, Atlan P, Dutot G & Puchstein C (2001) Effects of an olive oil based intravenous lipid emulsion (ILE) on plasma and leukocyte membrane fatty acid (FA) composition and on clinical outcomes in postoperative patients. Clin Nutr 20, suppl. 40.
55. Rocca AS, LaGreca J, Kalitsky J & Brubaker PL (2001) Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142, 1148-1155.
56. Rossle C, Breton I, Bereziat G, et al. (1992) Evolution of plasma phospholipid FA pattern in patients receiving postoperative TPN including soybean oil or olive oil-based lipid emulsions: a comparative multicenter study. Clin Nutr 11, suppl. 19.
57. Rubin M, Halpern Z, Charach G, Dvir A, Antebi E, Gilat T & Lichtenberg D (1992) Effect of lipid infusion on bile composition and lithogenicity in patients without cholesterol gallstones. Gut 33, 1400-1403.
58. Rubin M, Pakula R, Moser A, Halpern Z, Shimonov M & Lichtenberg D (1996) Does lipid infusion affect bile composition in humans? Isr J Med Sci 32, 1308-1313.
59. Sadeghi S, Wallace FA & Calder PC (1999) Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96, 404-410.
60. Schwacha MG & Chaudry IH (2002) The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 10, 239-243.
61. Seidner DL, Mascioli EA, Istfan NW, Porter KA, Selleck K, Blackburn GL & Bistrian BR (1989) Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. J Parenter Enter Nutr 13, 614-619.
62. Sparkes BG (1997) Immunological responses to thermal injury. Burns 23, 106-113.
63. Spielmann D, Bracco U, Traitler H, Crozier G, Holman R, Ward M & Cotter R (1988) Alternative lipids to usual n-6 PUFAS: γ-linolenic acid, α-linolenic acid, stearidonic acid, EPA, etc. J Parenter Enter Nutr 12, 111S-123S.
64. Suissa S & Shuster JJ (1985) Exact unconditional sample sizes for the 2 by 2 binomial trial. J Roy Statist Soc A148, 317-327.
65. Thomas-Gibson S, Jawhari AU, Atlan P, Le Brun A, Farthing A & Forbes A (2004) Safe and efficacious prologed use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure. Clin Nutr 23, 697-703.
66. Tobiasen J, Hiebert JM & Edlich RF (1982) The abbreviated burn severity index. Ann Emerg Med 11, 260-262.
67. Ueyama M, Maruyama I, Osame M & Sawada Y (1992) Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med 120, 693-698.
68. Vahedi K, Bereziat G, Le Brun A, Perennec V, Evard D, Atlan P, Dutot G & Messing B (1999) A randomised, double-blind 3-month study in home parenteral nutrition (HPN) patients with olive or soy oil-based lipid emulsions (ILE): safety, nutritional status, plasma and cell-membrane fatty acid profiles. Clin Nutr 18, Suppl. 48.
69. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P & Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345, 1359-1367.
70. Waitzberg DL, Bellinati Pires R, Salgado MM, Hypolito IP, Colleto GM, Yagi O, Yamamuro EM, Gama-Rodrigues J & Pinotti HW (1997) Effect of total parenteral nutrition with different lipid emulsions on human monocyte and neutrophils functions. Nutrition 13, 128-132.
71. Wanten GJA, Roos D & Naber AHJ (2000) Effects of structurally different lipid emulsions on human neutrophil migration. Clin Nutr 19, 327-331.
72. Warden GD, Wilmore DW, Rogers PW, Mason AD & Pruitt BA Jr (1973) Hypernatremic state in hypermetabolic burn patients. Arch Surg 106, 420-427.
73. Weissman C (1999) Nutrition in the intensive care unit. Crit Care 3, 67R-75R.
74. Yamada Y, Endo S & Inada K (1996) Plasma cytokine levels in patients with severe burn injury with reference to the relationship between infection and prognosis. Burns 22, 587-593.
75. Ythier-Moury P, Dutot G & Melin C (1990) Modifications of biliary secretion associated with parenteral nutrition in the rat: influence of fat emulsion composition. Clin Nutr 9, suppl. 26.
76. Zawacki BE, Azen SP, Imbus SH & Chang YT (1979) Multifactorial probit analysis of mortality in burned patients. Ann Surg 189, 1-5.